Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 50Lymphoma, Non-Hodgkin 45Lymphoma 34Lymphoma, Mantle-Cell 30Lymphoma, Follicular 26Multiple Myeloma 23Hodgkin Disease 21Lymphoma, Large B-Cell, Diffuse 18Recurrence 13Lymphoma, B-Cell, Marginal Zone 12Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 6Lymphoma, T-Cell 5Waldenstrom Macroglobulinemia 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, B-Cell 4Leukemia, Myeloid, Acute 4Leukemia, B-Cell 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Extranodal NK-T-Cell 3Immunoblastic Lymphadenopathy 3

Interventions

Dexamethasone 27Melphalan 22Cyclophosphamide 15Peripheral Blood Stem Cell Transplantation 14Filgrastim 13Bortezomib 12Calcium Dobesilate 9Lenalidomide 7fludarabine phosphate 6Whole-Body Irradiation 5Mycophenolic Acid 5Cyclosporine 5Thalidomide 4Interferon-alpha 4Etoposide 4Busulfan 4miridesap 3dexamethasone acetate 3Radiotherapy 3Epoetin Alfa 3Doxycycline 3Darbepoetin alfa 3Carboplatin 3pomalidomide 2liposomal amphotericin B 2ixazomib 2daratumumab 2birtamimab 2Thiotepa 2Tacrolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Immunoglobulin Light-chain Amyloidosis × Bendamustine Hydrochloride × Clear all
NCT01222260 2020-03-30

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

Columbia University

Phase 2 Completed
40 enrolled 10 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡